ECCO News

ECCO News keeps ECCO Members up-to-date on what is going on within the organisation and reports on IBD activities taking place within Europe. Since Spring 2006, ECCO News has maintained the flow of information between Members of the organisation. 

ECCO News is an important part of the European Crohn’s and Colitis Organisation’s ambition to create a European standard of IBD care and to promote knowledge and research in the field of IBD. 

Editor & Associate Editors

Alessandro Armuzzi
© Alessandro Armuzzi

Nuha Yassin
© ECCO

Ignacio Catalán-Serra
© Ignacio Catalán-Serra

Brigida Barberio
© Brigida Barberio

Spyros Siakavellas
© Spyros Siakavellas

Latest ECCO News Content


12December2017

We have MORE THAN a dream – your pioneer IBD platform, UR-CARE, is online NOW!

Julián Panés, ECCO President; Filip Baert, UR-CARE Steering Committee

07 UR CARE LOGO website

Dear friends and colleagues,

UR-CARE is online NOW!

This international database offered to you by ECCO’s research unit (IBDIM) has been designed for your patient records and your research studies.

Posted in ECCO News, UR-CARE News, Volume 12, Issue 4

12December2017

ECCO activities at UEG Week 2017

Laurent Peyrin-Biroulet, Editor, ECCO News

Laurent Peyrin BirouletLaurent Peyrin-Biroulet
© ECCO

I am happy to inform all ECCO members that the Governing Board started working while everybody was still on the plane! This year, we arrived on Friday afternoon and could already discuss numerous points. First, it was decided to continue increasing the amount of money for grants to foster exchange across ECCO centres and support innovative scientific projects. 

Posted in ECCO News, Governing Board, Committee News, Volume 12, Issue 4

12December2017

ECCO’18 – Come to Vienna for IBD!

02 Congress Banner

 

The 13th Congress of ECCO in Vienna is coming closer and so is the late registration deadline. Benefit from the late registration fee by registering up until January 31, 2018 (after this date the onsite registration fees will apply).

 

Posted in ECCO News, Congress News, ECCO'18, Volume 12, Issue 4

12December2017

Letter from the ECCO President

Julián Panés, ECCO President

Julian PanesJulián Panés  ©  ECCO

Dear ECCO friends,

We are witnessing an exciting period in the development of new therapies for Inflammatory Bowel Diseases. New therapeutic targets, and new classes of drugs, are being integrated into our therapeutic armamentarium. However, when we consider the proportion of patients who respond to induction therapy and, among those, the fraction who achieve remission during maintenance, the percentage of initially treated patients in whom the disease is satisfactorily controlled over one year does not exceed 15%30%.

Posted in ECCO News, Letters from the ECCO President, Volume 12, Issue 4